Irvine E J
Division of Gastroenterology, University of Toronto, Ontario, Canada.
Aliment Pharmacol Ther. 2004 Oct;20 Suppl 4:54-9. doi: 10.1111/j.1365-2036.2004.02053.x.
The management of chronic illness is becoming increasingly patient-centred. Although patients with inflammatory bowel disease have a normal life expectancy, most individuals experience an impact of inflammatory bowel disease on their daily lives as well as on their attitudes, fears and beliefs. Although currently available therapies for ulcerative colitis and Crohn's disease are becoming increasingly effective, there are still many unmet needs to address in this patient population. Physicians and patients' spouses or significant others underestimate the type and severity of problems reported by inflammatory bowel disease patients. Physical problems are frequently measured using disease activity indices. Emotional and social problems are reported using quality of life questionnaires and other specific measurement tools pertinent to the question of interest. Studies have indicated a poorer physical and emotional function in inflammatory bowel disease patients than in the general population. Effective therapies, both medical and surgical, produce significant improvements in the general and disease-specific quality of life. The quality of life is worse when the disease is more severe. Concomitant anxiety or depression appears to impair the quality of life even further. Common fears include the possibility of unanticipated flares, the need for surgery, poor energy levels and the side-effects of medication. Recent studies have suggested that more prominent patient participation in management has the potential for greater patient satisfaction, better outcomes and more efficient health resource utilization. Thus, future studies should focus not only on ensuring the wider availability of effective therapies, but on increasing access to health care that is tailored to individuals--more structure for some and more independence and self-management for others, with health provider supervision.
慢性病的管理正日益以患者为中心。尽管炎症性肠病患者的预期寿命正常,但大多数患者的日常生活以及他们的态度、恐惧和信念都受到炎症性肠病的影响。尽管目前用于治疗溃疡性结肠炎和克罗恩病的疗法越来越有效,但在这一患者群体中仍有许多未满足的需求有待解决。医生以及患者的配偶或重要他人低估了炎症性肠病患者所报告问题的类型和严重程度。身体问题通常使用疾病活动指数来衡量。情绪和社会问题则通过生活质量问卷以及与相关问题相关的其他特定测量工具来报告。研究表明,炎症性肠病患者的身体和情绪功能比普通人群更差。有效的医学和外科治疗能显著改善总体生活质量和疾病特异性生活质量。疾病越严重,生活质量越差。同时存在的焦虑或抑郁似乎会进一步损害生活质量。常见的恐惧包括意外发作的可能性、手术需求、精力水平低下以及药物副作用。最近的研究表明,患者更积极地参与管理有可能提高患者满意度、改善治疗效果并更有效地利用卫生资源。因此,未来的研究不仅应关注确保更广泛地提供有效治疗方法,还应关注增加获得针对个体量身定制的医疗保健服务——对一些人提供更多的结构化安排,对另一些人提供更多的独立性和自我管理,并由医疗服务提供者进行监督。